Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi

Journal of Clinical Oncology - United States
doi 10.1200/jco.2015.62.4817
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Dose Dense Abvd (Dd-Abvd) as First Line Therapy in Early-Stage Unfavorable Hodgkin Lymphoma (Hd): Results of a Phase Ii, Prospective Study by Fondazione Italiana Linfomi

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Response Oriented Maintenance Therapy in Advanced Follicular Lymphoma. Results of the Interim Analysis of the Foll12 Trial Conducted by the Fondazione Italiana Linfomi.

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Brentuximab Vedotin Followed by ABVD +/− Radiotherapy in Patients With Previously Untreated Hodgkin Lymphoma: Final Results of a Pilot Phase II Study

Haematologica
Hematology
2015English

Pet-Driven Radiotherapy in Patients With Low Risk Diffuse Large B-Cell Lymphoma (Dlbcl): The Dlcl10 Multicenter Phase 2 Trial by Fondazione Italiana Linfomi (Fil)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

The Elderly Project by the Fondazione Italiana Linfomi: A Prospective Comprehensive Geriatric Assessment (Cga) of 1353 Elderly Patients With Diffuse Large B-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Long-Term Quality of Life in Patients With Advanced Hodgkin Lymphoma: A Systematic Review

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Long-Term Results and Competing Risk Analysis of the H89 Trial in Patients With Advanced-Stage Hodgkin Lymphoma: A Study by the Groupe d'Etude Des Lymphomes De l'Adulte (GELA)

Blood
BiochemistryImmunologyCell BiologyHematology
2006English

UPDATED SAFETY AND EFFICACY RESULTS OF «HLMoscow 1-3» STUDY FOR THE 147 UNTREATED PATIENTS WITH ADVANCED CLASSICAL HODGKIN LYMPHOMA

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

EBV-Positive Plasmablastic Lymphoma Mimicking Reactive Lymphadenopathy Versus Recurrent Hodgkin Lymphoma Following Chemotherapy for Stage II Classical Hodgkin Lymphoma

Journal of Tumour Research & Reports
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy